Fresenius picks up M&A pace with Akorn, Merck KGaA deals [Reuters]
AKORN (AKRX)
Last akorn earnings: 10/31 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.akorn.com
Company Research
Source: Reuters
FILE PHOTO: The Fresenius SE headquarters are pictured in Bad Homburg near Frankfurt, Germany February 22, 2017. REUTERS/Ralph Orlowski By Ludwig Burger | FRANKFURT FRANKFURT German healthcare group Fresenius SE & Co KGaA ( FREG.DE ) has stepped up its dealmaking, agreeing to buy U.S. generic drugmaker Akorn Inc ( AKRX.O ) for $4.75 billion (4.37 billion euros) and the biosimilars arm of Germany's Merck KGaA. Takeovers were part of Fresenius's growth strategy under previous boss Ulf Mark Schneider, now leading Nestle ( NESN.S ). But his successor, former finance chief Stephan Sturm, is lifting the pace, having already bought a Spanish hospital chain for 5.8 billion euros since taking over in June. The latest deals are in keeping with Fresenius's focus on drugs that have lost patent protection, but also mark a foray into new dosage for
Show less
Read more
Impact Snapshot
Event Time:
AKRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKRX alerts
High impacting AKORN news events
Weekly update
A roundup of the hottest topics